Business
Press Release Feb 10 2023
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated February 10, 2023, titled "Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules".
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated February 10, 2023, titled \"Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules\". View Attachment","length":393,"tagName":"div"}]